60 related articles for article (PubMed ID: 26028942)
1. Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics.
Chandran K; Giridhar A; Desai S; Gopalakrishnan M; Indu VP; Sivaprasad S
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S125-S134. PubMed ID: 38131554
[TBL] [Abstract][Full Text] [Related]
2. Self-Supervised Learning for Improved Optical Coherence Tomography Detection of Macular Telangiectasia Type 2.
Gholami S; Scheppke L; Kshirsagar M; Wu Y; Dodhia R; Bonelli R; Leung I; Sallo FB; Muldrew A; Jamison C; Peto T; Lavista Ferres J; Weeks WB; Friedlander M; Lee AY;
JAMA Ophthalmol; 2024 Mar; 142(3):226-233. PubMed ID: 38329740
[TBL] [Abstract][Full Text] [Related]
3. Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption.
Ong JX; Zandi R; Fawzi AA
PLoS One; 2021; 16(11):e0259811. PubMed ID: 34767582
[TBL] [Abstract][Full Text] [Related]
4. Right-angled vessel characteristics in different stages of type 2 macular telangiectasia (MacTel).
Venkatesh R; Handa A; Chitturi SP; Choudhary A; Prabhu V; Acharya I; Mangla R; Yadav NK; Chhablani J
Eye (Lond); 2024 Apr; 38(6):1162-1167. PubMed ID: 38012385
[TBL] [Abstract][Full Text] [Related]
5. Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease Grading.
Wu Y; Egan C; Olvera-Barrios A; Scheppke L; Peto T; Charbel Issa P; Heeren TFC; Leung I; Rajesh AE; Tufail A; Lee CS; Chew EY; Friedlander M; Lee AY
Ophthalmology; 2024 Feb; 131(2):219-226. PubMed ID: 37739233
[TBL] [Abstract][Full Text] [Related]
6. METHYLATION-ASSOCIATED PATHWAYS IN MACULAR TELANGIECTASIA TYPE 2 AND OPHTHALMOLOGIC FINDINGS IN PATIENTS WITH GENETIC METHYLATION DISORDERS.
Pauleikhoff L; Wingert V; Grünert SC; Lange C; Hannibal L; Bucher F
Retina; 2024 Jun; 44(6):1052-1062. PubMed ID: 38261977
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients.
Totsuka K; Aoki S; Arai T; Kitamoto K; Azuma K; Fujino R; Inoue T; Obata R
Sci Rep; 2023 Nov; 13(1):18954. PubMed ID: 37919473
[TBL] [Abstract][Full Text] [Related]
8. Hyperpigmented epiretinal membrane in macular telangiectasia type 2: imaging characteristics and correlation with transretinal pigment migration.
Cabral D; Ramtohul P; Kaden TR; Tenreiro S; Seabra MC; Freund KB
Eye (Lond); 2023 Jun; 37(9):1856-1860. PubMed ID: 36138103
[TBL] [Abstract][Full Text] [Related]
9. Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia.
Reddy NG; Prabhu V; Sharma SV; Acharya I; Mangla R; Yadav NK; Chhablani J; Narayanan R; Venkatesh R
Int J Retina Vitreous; 2023 Aug; 9(1):47. PubMed ID: 37559099
[TBL] [Abstract][Full Text] [Related]
10. Timing of ocular examination and retinal imaging for the diagnosis of type 2 macular telangiectasia (MacTel).
Sharief S; Venkatesh R; Mangla R; Chhablani J
Eur J Ophthalmol; 2023 Nov; 33(6):NP79-NP81. PubMed ID: 36788478
[TBL] [Abstract][Full Text] [Related]
11. A complete clinical review of idiopathic macular telangiectasia.
Jayasri P; Stephen AM
Oman J Ophthalmol; 2023; 16(3):421-426. PubMed ID: 38059108
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. The 2022 founders lecture of the pan American vitreoretinal society.
Wu L
Int J Retina Vitreous; 2023 Nov; 9(1):69. PubMed ID: 37968753
[TBL] [Abstract][Full Text] [Related]
13. Macular telangiectasia with bilateral obliterated capillaries: a case report.
Samadi M; Azarkish A; Riazi-Esfahani H; Mahmoudi A; Ebrahimiadib N
J Med Case Rep; 2022 Oct; 16(1):372. PubMed ID: 36224668
[TBL] [Abstract][Full Text] [Related]
14. Demographic features of idiopathic macular telangiectasia in Korean patients.
Kim SH; Oh J; Ahn SE; Park CY; Oh JH
Korean J Ophthalmol; 2015 Jun; 29(3):155-9. PubMed ID: 26028942
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
[TBL] [Abstract][Full Text] [Related]
16. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
[TBL] [Abstract][Full Text] [Related]
17. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
18. [Idiopathic macular telangiectasia: clinical appearance, imaging and treatment].
De Bats F; Denis P; Kodjikian L
J Fr Ophtalmol; 2013 Feb; 36(2):164-71. PubMed ID: 23200165
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics, multimodality imaging and treatment of macular telangiectasia type 2].
Cai Y; Shi X; Zhao MW; Li XX
Zhonghua Yan Ke Za Zhi; 2019 Jan; 55(1):68-73. PubMed ID: 30641677
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
